2',3'-Dideoxynucleoside Synthesis via 3'-to-5' Inversion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing 2′,3′-dideoxynucleosides like 2′,3′-dideoxyguanosine, 2′,3′-dideoxyadenosine, 3′-deoxythymidine, and 2′,3′-dideoxyuridine are labor-intensive and costly, particularly due to the lack of suitable commercial products and efficient attachment methods, especially for 3′-deoxythymidine, which faces challenges in maintaining the thymine base during oligonucleotide deprotection.

Innovation Solution

The methods involve reacting 2′,3′-dideoxynucleosides with specific reagents such as N,N-dimethylformamide dimethylacetal and 4,4-dimethoxytriphenylmethyl chloride, followed by coupling with solid supports like long chain alkyl amine/controlled pore glass beads, to create stable support structures for use in pyrophosphorolysis-activated polymerization, enabling efficient synthesis and detection of nucleic acids.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If terminal transferase or 5'-to-3' reverse synthesis is used to synthesize ddN-terminated oligonucleotides, then the PAP process can be performed, but the synthesis process becomes labor intensive and costly

Engineering Contradiction:
ImprovePAP process capabilityVSAvoidsynthesis process simplicity
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent inverts the conventional 5'-to-3' reverse synthesis approach by implementing 3'-to-5' synthesis. Instead of building oligonucleotides from the 5' end and adding ddN terminators, the method synthesizes directly from the 3' end, naturally incorporating the ddN terminus as the starting point. This inversion eliminates the need for terminal transferase or complex reverse synthesis procedures, reducing labor intensity and cost while maintaining PAP process capability.

Inventive Principle:
Principle #13The other way round (Inversion)

Solution Approach 2:

The patent introduces a novel 3'-ddN phosphoramidite intermediate that serves as a mediator for direct oligonucleotide synthesis. This intermediate contains the ddN terminator already positioned at the 3' end, allowing standard phosphoramidite chemistry to build the oligonucleotide chain in the 3'-to-5' direction. This intermediary compound simplifies the overall synthesis process by eliminating the need for post-synthesis modification or complex enzymatic steps.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If 5'-to-3' reverse synthesis is used to obtain dT-containing DNA, then oligonucleotides can be synthesized, but the process becomes expensive and labor intensive

Engineering Contradiction:
ImprovedT-containing DNA synthesisVSAvoidsynthesis efficiency
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The patent applies the inversion principle specifically to thymidine-containing oligonucleotides by implementing 3'-to-5' synthesis that naturally incorporates dT residues. The 3'-ddT phosphoramidite serves as the starting intermediate, allowing direct synthesis of dT-containing DNA without expensive 5'-to-3' reverse synthesis. This approach maintains ease of manufacture while significantly improving productivity through streamlined synthesis steps.

Inventive Principle:
Principle #13The other way round (Inversion)

3Strength

If 4-oxo oxygen attachment is used for 3'-deoxythymidine, then covalent linkage can be formed, but the alkoxide is displaced by nitrogen nucleophiles during deprotection, converting thymine to cytidine derivative

Engineering Contradiction:
Improvecovalent linkage formationVSAvoidthymine base stability
Core Design Contradiction:
StrengthVSStability of the object's composition

Solution Approach 1:

The patent introduces a 3'-ddN phosphoramidite intermediate as a mediator that protects the thymine base during synthesis and deprotection. The phosphoramidite chemistry provides a stable linkage that is not susceptible to displacement by nitrogen nucleophiles. This intermediary approach allows covalent linkage formation while maintaining thymine base stability throughout the deprotection process, preventing conversion to cytidine derivatives.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the chemical parameters of the attachment mechanism by using phosphoramidite chemistry instead of direct 4-oxo oxygen linkage. This parameter change modifies the reactivity profile, making the linkage stable against nitrogen nucleophile attack during deprotection. The phosphoramidite intermediate allows controlled reaction conditions that preserve thymine base integrity while forming stable covalent linkages.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These methods provide a cost-effective and efficient means to synthesize and utilize 2′,3′-dideoxynucleosides, facilitating allele-specific amplification and detection with high specificity, addressing the limitations of existing synthesis techniques.

Implementation Method 1

reacting 2′,3′-dideoxynucleosides with specific reagents such as N,N-dimethylformamide dimethylacetal and 4,4-dimethoxytriphenylmethyl chloride

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Implementation Method 2

The chemistry involved in the process of pyrophosphorolysis is the reaction of pyrophosphate with a 3′-nucleotide monophosphate (NMP) which is removed from duplex DNA

Methodology Applied
Scientific EffectPyrophosphorolysis: Hydrolysis

Implementation Method 3

coupling with solid supports like long chain alkyl amine/controlled pore glass beads, to create stable support structures

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentUS8658776B2Synthesis of 2',3'-dideoxynucleosides for automated DNA synthesis and pyrophosphorolysis activated polymerization
Publication Date: 2014.02.25 LIFE TECHNOLOGIES CORP
  • US8658776B2 patent drawing
  • US8658776B2 patent drawing
  • US8658776B2 patent drawing

AI summary

Methods for preparation of 2′,3′-dideoxynucleotides support structures, such as 2′,3′-dideoxyguanosine, 2′,3′-dideoxyadenosine, and 3′-deoxythymidine support structures are disclosed. Various methods of using such structures are also provided, such as their use for automated DNA synthesis and pyrophosphorolysis activated polymerization.